| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 339K | $36.7M | $108.00 | 28 Feb 2023 | Direct |
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Option (right to buy) | 62.5K | 17 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28 Feb 2023 | 1 | -$623K | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2023, 18:23 |
| ABT | ABBOTT LABORATORIES | 17 Feb 2023 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 22 Feb 2023, 17:43 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2022 | 1 | -$867K | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2022, 18:35 |
| ABT | ABBOTT LABORATORIES | 18 Feb 2022 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 23 Feb 2022, 19:04 |
| ABT | ABBOTT LABORATORIES | 13 Dec 2021 | 3 | -$15M | 4 | EXECUTIVE VICE PRESIDENT | 15 Dec 2021, 17:32 |